This trial is active, not recruiting.

Condition healthy subjects
Treatment blood collection
Sponsor Pfizer
Start date August 2006
End date December 2016
Trial size 900 participants
Trial identifier NCT00401232, 6108A1-800, B1971032


This is a study to collect blood from volunteers to assist in assay development.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Allocation non-randomized
Intervention model single group assignment
Primary purpose diagnostic
blood collection
Blood Collection

Primary Outcomes

"No outcome measures". Blood collected for assay development.
time frame: 1 hour

Eligibility Criteria

Male or female participants from 18 years up to 64 years old.

Inclusion Criteria: - Healthy Volunteers aged 18-64 Exclusion Criteria: - Bleeding disorder

Additional Information

Official title Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay Development
Trial information was received from ClinicalTrials.gov and was last updated in December 2016.
Information provided to ClinicalTrials.gov by Pfizer.